| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/16/2005 | EP0634896B1 Evaluation of patients with progressive immunosuppression |
| 02/16/2005 | CN1579554A Gene-carrying micro-bublle of target transfergene, its preparation method and use |
| 02/16/2005 | CN1189218C Multi-stage method for producing gas-filled microcapsules |
| 02/16/2005 | CN1189217C Ending vascular embolism preparation |
| 02/15/2005 | US6855828 Administering to a mammal a fluorine-18 containing 2-nitro-n-(carboxamidomethyl)imidazole derivatives and imaging |
| 02/15/2005 | US6855709 Psychological disorders; central nervous system disorders |
| 02/15/2005 | US6855504 In vivo high throughput toxicology screening method |
| 02/15/2005 | US6855309 For use in diagnostics and therapy |
| 02/15/2005 | US6855308 Anticancer, antitumor agents |
| 02/10/2005 | WO2005012509A2 Method for immunotherapy of tumors |
| 02/10/2005 | WO2005011810A1 Magnetic particles for therapeutic treatment |
| 02/10/2005 | WO2005011738A2 Polymeric conjugates containing phosphine - based chelating groups |
| 02/10/2005 | WO2005011612A2 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism |
| 02/10/2005 | WO2004103164A3 Method and apparatus for homeopathic provings and diagnosis |
| 02/10/2005 | WO2004091397A3 Method of determining state variables and changes in state variables |
| 02/10/2005 | WO2003050295A3 Assays and implements for determining and modulating hsp90 binding activity |
| 02/10/2005 | US20050033057 Thiazoline acid derivatives |
| 02/10/2005 | US20050033018 Receptors and membrane-associated proteins |
| 02/10/2005 | US20050032148 Diagnostic agents for pancreatic exocrine function |
| 02/10/2005 | US20050031640 Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma |
| 02/10/2005 | US20050031616 Controlled platelet activation to monitor therapy of ADP antagonists |
| 02/10/2005 | US20050031544 Receptor mediated nanoscale copolymer assemblies for diagnostic imaging and therapeutic management of hyperlipidemia and infectious diseases |
| 02/10/2005 | US20050031543 Contrast agents |
| 02/10/2005 | US20050031542 using carbocyanine dyes; photodynamic therapy; supplying to tumors |
| 02/10/2005 | US20050031541 Diagnosis and treatment of cervical and bladder cancer using hexyl 5-aminolevulinate as a photosensitizer; improved photochemotherapeutic properties; antineoplastic agents |
| 02/10/2005 | US20050031539 X-ray-detectable fiber and medical absorbent gauze including the same |
| 02/10/2005 | US20050031538 Administering an agent to a test animal and determining responses of cells of brain marrow tissues, including irradiated brain marrow tissue depleted of neurogenic stems cells, and cells in brain marrow-derived neurospheres cultured in vitro; measuring neurogenesis |
| 02/10/2005 | US20050031537 Multifunctional COX-2 inhibitors |
| 02/10/2005 | US20050031536 Methods and compositions comprising monitoring devices |
| 02/10/2005 | US20050030026 Enhancement of NMR and MRI in the presence of hyperpolarized noble gases |
| 02/10/2005 | CA2537899A1 Tissue-specific targeting of therapeutic and imaging agents to caveolae |
| 02/10/2005 | CA2534377A1 Method for immunotherapy of tumors |
| 02/09/2005 | EP1503805A1 Lyophilized edible food incorporating a marker |
| 02/09/2005 | EP1503803A1 Medicinal formulation in particular for treating herniated invertebral discs |
| 02/09/2005 | EP1503802A2 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 02/09/2005 | EP1503800A1 Treatment and prevention of tissue damage |
| 02/09/2005 | EP1503734A2 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head |
| 02/09/2005 | EP1287359A4 Coated nanoparticles |
| 02/09/2005 | CN1578910A Neurofibrillary labels |
| 02/08/2005 | US6852906 Monitoring enzyme activity in cells; obtain cells, incubate with labeled substrate, detect adjustment in physical properties of cell, adjustment in physical property indicates enzyme activity |
| 02/08/2005 | US6852874 Second cycle asymmetric dihydroxylation reaction |
| 02/08/2005 | US6852842 Methods for functional kidney imaging using small dendrimer contrast agents |
| 02/08/2005 | US6852698 Free radical scavengers or promoters thereof as therapeutic adjuvants in preterm parturition |
| 02/08/2005 | US6852496 Without causing immunosuppression; improves healing time |
| 02/08/2005 | US6852334 Cationic peg-lipids and methods of use |
| 02/08/2005 | US6852308 Iodinated and/or brominated derivatives of aromatic dihydroxy monomers are prepared and polymerized to form radio-opaque polymers. The monomers may also be copolymerized with other dihydroxy monomers. The iodinated and brominated aromatic |
| 02/03/2005 | WO2005010677A2 Characterizing biological stimuli by response curves |
| 02/03/2005 | WO2005009478A1 Method of magnetically labeling vital cell using inactivated viral envelope and nuclear magnetic resonance contrast agent |
| 02/03/2005 | WO2005009429A1 Compositions containing prodrugs of florfenicol and methods of use |
| 02/03/2005 | WO2005009412A1 Oral compositions for treatment of diseases |
| 02/03/2005 | WO2005009366A2 Restoring vascular function |
| 02/03/2005 | WO2005009222A2 Method of determining sperm capacitation |
| 02/03/2005 | WO2005009119A1 Rat model of diabetic nephropathy |
| 02/03/2005 | WO2004100998A3 Compositions and methods for non-invasive imaging of soluble beta-amyloid |
| 02/03/2005 | WO2004006860A3 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 02/03/2005 | WO2003040317A8 Lung cancer therapeutics and diagnostics |
| 02/03/2005 | US20050028230 Expresion vector comprising nucleotide sequences coding membrane glycoprotein for use in generation of transgenic animal models for identifying modulators which reduce concentration of preferential biological agents in tissues of cells |
| 02/03/2005 | US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders |
| 02/03/2005 | US20050026866 Detecting or treating mammalian tumor cells; tissue-targeted therapy; genetic engineered Bordetella pertussis; biodrugs |
| 02/03/2005 | US20050026840 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics |
| 02/03/2005 | US20050026839 Conformationally constrained parathyroid hormone (pth) analogs |
| 02/03/2005 | US20050026228 Using concentration of receptor protein tyrosine kinase polypeptide/adaptor complex as diagnostic indicator of cell proliferative disorders; turmor diagnosis and treatment |
| 02/03/2005 | US20050026211 Compositions and methods relating to lung specific genes |
| 02/03/2005 | US20050025971 Inorganic reaction product containing iron oxide and transition metal oxide |
| 02/03/2005 | US20050025749 Grafting heart tissue; closure of heart defect |
| 02/03/2005 | US20050025711 Contrast media formulations having improved biological tolerance |
| 02/03/2005 | US20050025710 Controlled bubble size |
| 02/03/2005 | US20050025709 Immunological reagents for therapeutic use, for example, in radioimmunotherapy (RAIT), and diagnostic use, for example, in radioimmunodetection (RAID) and magnetic resonance imaging |
| 02/03/2005 | US20050025705 Causing occlusion to blood vessels using ferric chloride solution, introducing test compound and measuring physical or chemical alterations; simple, sensitive screening technique |
| 02/03/2005 | US20050025702 radiotherapeutic or chemotherapeutic agents comprising metalloenzyme inhibitors and chelation compounds capable of conjugating to cytotoxic radioisotopes; anticarcinogenic agents |
| 02/03/2005 | DE10331439B3 Magnetische Nanopartikel mit verbesserten Magneteigenschaften Magnetic nanoparticles with improved magnetic properties |
| 02/03/2005 | CA2536111A1 Oral compositions for treatment of diseases |
| 02/03/2005 | CA2533542A1 Method of determining sperm capacitation |
| 02/03/2005 | CA2533315A1 Rat model of diabetic nephropathy |
| 02/03/2005 | CA2531223A1 Compositions containing prodrugs of florfenicol and methods of use |
| 02/02/2005 | EP1502106A1 Bio-spectral imaging system and methods for diagnosing cell disease state |
| 02/02/2005 | EP1501940A1 Method for phenotyping using nmr spectroscopy |
| 02/02/2005 | EP1501860A2 Modulation of heat-shock-protein-based immunotherapies |
| 02/02/2005 | EP1501552A1 Mr-signal emitting coatings |
| 02/02/2005 | EP1501524A2 Internal image antibodies for optical imaging and therapy |
| 02/02/2005 | EP1501496A2 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
| 02/02/2005 | EP1501476A2 Compositions and methods for in situ and in vivo imaging of cells and tissues |
| 02/02/2005 | EP1189546B1 Biopsy site marker and apparatus for applying it |
| 02/02/2005 | EP0971677B1 Bone cement and method of preparation |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575299A Homing peptides |
| 02/01/2005 | US6849249 Contactor eye tissue with compound that binds to amyloid protein |
| 01/27/2005 | WO2005007868A2 Controlled platelet activation to monitor therapy of adp antagonists |
| 01/27/2005 | WO2005007284A2 Composite nanoparticles |
| 01/27/2005 | WO2005007200A1 Stationary target mr imaging |
| 01/27/2005 | WO2004091395A3 Method for spatially resolved determination of magnetic particle distribution in an area of examination |
| 01/27/2005 | WO2004082517A3 Animal exhibiting ptsd-like behavior, per pct rule 4.3 |
| 01/27/2005 | WO2004064740A3 Sperm specific lysozyme-like proteins |
| 01/27/2005 | WO2004060053A3 Transgenic mice expressing human cd20 |
| 01/27/2005 | WO2004060041A3 Kim-1 antagonists and use to modulate immune system |
| 01/27/2005 | US20050022258 Genetically determined mouse model of resistance to transplantable cancers |
| 01/27/2005 | US20050020931 Management of gastro-intestinal disorders |
| 01/27/2005 | US20050020923 Materials and methods for near-infrared and infrared lymph node mapping |
| 01/27/2005 | US20050020922 Materials and methods for near-infrared and infrared intravascular imaging |
| 01/27/2005 | US20050020899 Post-biopsy cavity treatmetn implants and methods |